BSE Live
Sep 05, 16:01Prev. Close
86.57
Open Price
87.61
Bid Price (Qty.)
86.00 (100)
Offer Price (Qty.)
90.00 (679)
NSE Live
Sep 05, 15:54Prev. Close
86.69
Open Price
87.55
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
86.89 (39)
Balance Sheet of Omaxe (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 182.90 | 182.90 | 182.90 | 182.90 | 182.90 | |
Total Share Capital | 182.90 | 299.38 | 282.65 | 268.17 | 255.79 | |
Reserves and Surplus | 474.52 | 465.33 | 831.50 | 1,025.04 | 873.69 | |
Total Reserves and Surplus | 474.52 | 465.33 | 831.50 | 1,025.04 | 873.69 | |
Total Shareholders Funds | 657.42 | 764.71 | 1,114.15 | 1,293.21 | 1,129.48 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 145.91 | 36.14 | 96.47 | 171.02 | 321.50 | |
Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Long Term Liabilities | 53.89 | 76.81 | 54.76 | 130.76 | 103.58 | |
Long Term Provisions | 10.68 | 9.29 | 8.42 | 7.54 | 12.13 | |
Total Non-Current Liabilities | 210.48 | 122.24 | 159.65 | 309.32 | 437.21 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 96.97 | 54.79 | 120.29 | 239.47 | 99.62 | |
Trade Payables | 420.35 | 419.94 | 448.35 | 393.85 | 414.07 | |
Other Current Liabilities | 4,903.29 | 4,305.32 | 3,965.57 | 3,611.14 | 3,656.75 | |
Short Term Provisions | 1.79 | 1.21 | 1.25 | 1.44 | 0.65 | |
Total Current Liabilities | 5,422.40 | 4,781.26 | 4,535.46 | 4,245.90 | 4,171.09 | |
Total Capital And Liabilities | 6,290.30 | 5,893.43 | 5,809.26 | 5,848.43 | 5,963.00 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 453.24 | 493.06 | 508.30 | 544.90 | 590.51 | |
Intangible Assets | 30.58 | 0.14 | 0.20 | 0.11 | 0.09 | |
Capital Work-In-Progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 483.82 | 493.20 | 508.50 | 545.01 | 590.60 | |
Non-Current Investments | 393.52 | 383.62 | 336.36 | 295.07 | 294.19 | |
Deferred Tax Assets [Net] | 301.02 | 312.83 | 269.72 | 211.75 | 200.56 | |
Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 10.32 | |
Other Non-Current Assets | 188.46 | 173.00 | 159.83 | 174.75 | 144.20 | |
Total Non-Current Assets | 1,366.82 | 1,362.65 | 1,274.41 | 1,226.58 | 1,239.87 | |
CURRENT ASSETS | ||||||
Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Inventories | 2,279.35 | 2,181.44 | 2,315.58 | 2,305.33 | 2,316.22 | |
Trade Receivables | 204.62 | 239.87 | 250.60 | 246.38 | 245.29 | |
Cash And Cash Equivalents | 261.23 | 244.65 | 197.86 | 211.89 | 192.58 | |
Short Term Loans And Advances | 837.76 | 444.78 | 417.35 | 719.06 | 930.13 | |
OtherCurrentAssets | 1,340.52 | 1,420.04 | 1,353.46 | 1,139.19 | 1,038.91 | |
Total Current Assets | 4,923.48 | 4,530.78 | 4,534.85 | 4,621.85 | 4,723.13 | |
Total Assets | 6,290.30 | 5,893.43 | 5,809.26 | 5,848.43 | 5,963.00 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 0.00 | 1,294.35 | 1,144.33 | 905.97 | 1,146.47 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 0.00 | 1.58 | 1.35 | 0.00 | 0.00 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | -- | -- | -- | -- | -- | |
Other Earnings | -- | -- | -- | -- | -- | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | -- | 151.15 | 151.15 | 151.15 | 151.15 | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | 12.60 | 336.36 | -- | -- | |
Non-Current Investments Unquoted Book Value | -- | -- | -- | -- | -- | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
03.06.2025
Omaxe Consolidated March 2025 Net Sales at Rs 541.26 crore, up 1.06% Y-o-Y
30.05.2025
Omaxe Standalone March 2025 Net Sales at Rs 138.17 crore, down 18.02% Y-o-Y
20.02.2025
Omaxe Consolidated December 2024 Net Sales at Rs 288.94 crore, down 51.78% Y-o-Y
12.02.2025
Omaxe Standalone December 2024 Net Sales at Rs 76.03 crore, down 65.54% Y-o-Y
09.10.2017
20.04.2017
18.04.2017
17.04.2017
26.02.2017
24.02.2017
15.02.2017
14.02.2017